45 results
8-K
EX-99.1
INVA
Innoviva Inc
29 Feb 24
Innoviva Reports Fourth Quarter and Full Year 2023 Financial Results; Highlights Recent Company Progress
4:15pm
/BREO® ELLIPTA® and ANORO® ELLIPTA®. Innoviva’s other innovative healthcare assets include infectious disease and critical care assets stemming from
8-K
EX-99.1
INVA
Innoviva Inc
1 Nov 23
Innoviva Reports Third Quarter 2023 Financial Results and Highlights Recent Company Progress
4:30pm
innovative healthcare assets include infectious disease and hospital assets stemming from acquisitions of Entasis Therapeutics, including XACDURO®
8-K
EX-99.1
129e6qlhyni9 vym
2 Aug 23
Innoviva Reports Second Quarter 2023 Financial Results and Highlights Recent Company Progress
4:15pm
8-K
EX-99.1
4iwioa5
24 May 23
Corporate Presentation May 2023
5:18pm
8-K
EX-99.1
j8lgyl
9 May 23
Innoviva Reports First Quarter 2023 Financial Results and Highlights Recent
5:21pm
8-K
EX-99.1
ymqh7nz9nfpfry k01zq
14 Sep 22
Regulation FD Disclosure
5:22pm
SC TO-T/A
EX-99
jsg3ana
22 Aug 22
Third party tender offer statement (amended)
9:08am
SC TO-T
EX-99
kzk9qp3l 35123us9l3g
25 Jul 22
Third party tender offer statement
8:34am
8-K
EX-99.1
ggllxgcnnxoo35
13 Jul 22
Entry into a Material Definitive Agreement
5:27pm
SC TO-C
yyk28
11 Jul 22
Information about tender offer
3:46pm
SC TO-C
EX-99.1
wuitffxg
11 Jul 22
Information about tender offer
3:46pm
8-K
EX-99.1
3b70njueudomcbhv51
11 Jul 22
Innoviva to Acquire La Jolla Pharmaceutical Company
7:38am
8-K
zjrvv3 dyul6
11 Jul 22
Innoviva to Acquire La Jolla Pharmaceutical Company
7:38am